The International Journal of Cancer Medicine, with a DOI prefix of 10.46619 and an Impact Factor of 4.2, is a peer-reviewed open access journal that covers all aspects of cancer research, particularly novel concepts and theories, new techniques, therapeutic agents, and alternative approaches for early detection and intervention of cancer.
The journal's objective is to advance the field of cancer or oncology by publishing articles focused on disease management, prevention, early diagnosis methods, specific classes of therapeutic agents, clinical trial results, emerging interventional techniques, supportive care, and rehabilitation /reconstruction. The journal's rigorous single-blinded peer-review process ensures the rapid publication of high-quality cancer research results.
Currently, all students and emeritus professors can submit and publish their manuscripts at a discounted rate. Additionally, the published articles are available to online readers free of charge.
Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS, http://nihms.nih.gov/).
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC https://www.coronavirus.gov
Get the latest research https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Valéry Refeno, Rova Malala Fandresena Randrianarisoa, Hery Randrianirina, Ernestine Faly, Giannie Rasamimanana, Andriambelo Tovohery Rajaonera and Florine Rafaramino
Rasit Dinc
Yongli Situ, Xiaoli Jiang, Ziqing Huang, Juying Zhang, Lingling Lu, Quanyan Liang, Li Deng, Qinying Xu and Zheng Shao
Cong-yu Zhang, Li Zhang, Hong-zhi Sun, Min-wen Ha, Zheng-guo Cui and Hua-chuan Zheng
Timothy Schieber, Matthew Arango, Kathryn Herr, Missy Sweeney, Eric Mclaughlin, Anne Noonan, and Daniel Kendzierski
Dedy Hermansyah and Muhammad Al Anas
Sandeep kumar Jasuja, Mukesh Kumar, Aditi Mittal, Krutika Goyal, Sajna Choudhary, Ashish Dayma, Linu Hooda and Jaiprakash Yadav
Serap Yucel, Zeynep Gural, Mustafa Sungur, Leyla Ozer, Harzem Özger and Fulya Ağaoğlu
Michael J Dochniak
Soufiène Gabsi, Wael Ferjaoui, Achref Sarraj, Atef Mejri, Lasaad Gharbi and Malek Bakhtri
The primary objective of the International Journal of Cancer Medicine is to enhance and disseminate knowledge and global health outcomes by promptly publishing top-quality research articles, reviews, and case reports conveying important practice messages to the scientific community. The journal welcomes all types of articles covering various areas of Cancer Biology, Clinical Cancer Research, Cancer Prevention, and related fields, with the belief that the best research should be rapidly published and made widely accessible.
The International Journal of Cancer Medicine will accept submissions from all oncological specialties, including, but not limited to, the following areas: